{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T16:19:11Z","timestamp":1790957951331,"version":"4.1.0"},"reference-count":80,"publisher":"Frontiers Media SA","content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurosci."],"DOI":"10.3389\/fnins.2016.00243","type":"journal-article","created":{"date-parts":[[2016,5,30]],"date-time":"2016-05-30T23:09:00Z","timestamp":1464649740000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":116,"title":["CB2 Cannabinoid Receptor As Potential Target against Alzheimer's Disease"],"prefix":"10.3389","volume":"10","author":[{"given":"Ester","family":"Aso","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isidro","family":"Ferrer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2016,5,31]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"489","DOI":"10.3233\/JAD-150913","article-title":"Cannabinoid receptor 2 participates in amyloid-\u03b2 processing in a mouse model of Alzheimer's disease but plays a minor role in the therapeutic properties of a cannabis-based medicine","volume":"51","author":"Aso","year":"2016","journal-title":"J. Alzheimers Dis."},{"issue":"37","key":"B2","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2014.00037","article-title":"Cannabinoids for treatment of Alzheimer's disease: moving toward the clinic","volume":"5","author":"Aso","year":"2014","journal-title":"Front. Pharmacol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"847","DOI":"10.3233\/JAD-130137","article-title":"CB2 cannabinoid receptor agonist ameliorates Alzheimer-like phenotype in A\u00dfPP\/PS1 mice","volume":"35","author":"Aso","year":"2013","journal-title":"J. Alzheimers Dis."},{"key":"B4","doi-asserted-by":"publisher","first-page":"977","DOI":"10.3233\/JAD-141014","article-title":"Cannabis-based medicine reduces multiple pathological processes in A\u00dfPP\/PS1 mice","volume":"43","author":"Aso","year":"2015","journal-title":"J. Alzheimers Dis."},{"key":"B5","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.lfs.2014.12.016","article-title":"Enhanced microglial activity in FAAH(\u2212\/\u2212) animals","volume":"138","author":"Ativie","year":"2015","journal-title":"Life Sci."},{"key":"B6","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1111\/j.1476-5381.2010.00729.x","article-title":"CB2: a cannabinoid receptor with an identity crisis","volume":"160","author":"Atwood","year":"2010","journal-title":"Br. J. Pharmacol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.pnpbp.2011.12.001","article-title":"CB2: therapeutic target-in-waiting","volume":"38","author":"Atwood","year":"2012","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"B8","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.mcn.2013.06.004","article-title":"Role of the cannabinoid system in the transit of beta-amyloid across the blood-brain barrier","volume":"56","author":"Bachmeier","year":"2013","journal-title":"Mol. Cell. Neurosci."},{"key":"B9","doi-asserted-by":"crossref","first-page":"11136","DOI":"10.1523\/JNEUROSCI.23-35-11136.2003","article-title":"Cannabinoid CB2 receptors and fatty acid amide hydrolase are selectively overexpressed in neuritic plaque-associated glia in Alzheimer's disease brains","volume":"23","author":"Benito","year":"2003","journal-title":"J. Neurosci."},{"key":"B10","doi-asserted-by":"publisher","first-page":"e11","DOI":"10.1016\/j.neurobiolaging.2010.07.009","article-title":"Early onset of aging-like changes is restricted to cognitive abilities and skin structure in Cnr1(\u2212\/\u2212) mice","volume":"33","author":"Bilkei-Gorzo","year":"2012","journal-title":"Neurobiol. Aging"},{"key":"B11","doi-asserted-by":"publisher","first-page":"15670","DOI":"10.1073\/pnas.0504640102","article-title":"Early age-related cognitive impairment in mice lacking cannabinoid CB1 receptors","volume":"102","author":"Bilkei-Gorzo","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B12","doi-asserted-by":"publisher","first-page":"3326","DOI":"10.1098\/rstb.2011.0388","article-title":"The endocannabinoid system in normal and pathological brain ageing","volume":"367","author":"Bilkei-Gorzo","year":"2012","journal-title":"Philos. Trans. R. Soc. Lond. B Biol. Sci."},{"key":"B13","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.cbpa.2009.04.619","article-title":"Alzheimer's disease: new approaches to drug discovery","volume":"13","author":"Bolognesi","year":"2009","journal-title":"Curr. Opin. Chem. Biol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/BF00308809","article-title":"Neuropathological stageing of Alzheimer-related changes","volume":"82","author":"Braak","year":"1991","journal-title":"Acta Neuropathol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/S0014-2999(00)00211-9","article-title":"Immunomodulation by cannabinoids is absent in mice deficient for the cannabinoid CB(2) receptor","volume":"396","author":"Buckley","year":"2000","journal-title":"Eur. J. Pharmacol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"e3","DOI":"10.1017\/S1462399409000957","article-title":"Emerging role of the cannabinoid receptor CB2 in immune regulation: therapeutic prospects for neuroinflammation","volume":"11","author":"Cabral","year":"2009","journal-title":"Expert Rev. Mol. Med."},{"key":"B17","doi-asserted-by":"publisher","first-page":"973","DOI":"10.3233\/JAD-140093","article-title":"The potential therapeutic effects of THC on Alzheimer's disease. J","volume":"42","author":"Cao","year":"2014","journal-title":"Alzheimers Dis."},{"key":"B18","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1016\/j.celrep.2012.09.030","article-title":"Monoacylglycerol lipase is a therapeutic target for Alzheimer's disease","volume":"2","author":"Chen","year":"2012","journal-title":"Cell Rep."},{"key":"B19","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1016\/j.cell.2013.10.042","article-title":"\u0394(9)-THC-caused synaptic and memory impairments are mediated through COX-2 signaling","volume":"155","author":"Chen","year":"2013","journal-title":"Cell"},{"key":"B20","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1038\/ncb1901","article-title":"Transmission and spreading of tauopathy in transgenic mouse brain","volume":"11","author":"Clavaguera","year":"2009","journal-title":"Nat. Cell Biol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.nbd.2014.05.001","article-title":"Early detection of Alzheimer's disease using PiB and FDG PET","volume":"72","author":"Cohen","year":"2014","journal-title":"Neurobiol. Dis."},{"key":"B22","doi-asserted-by":"publisher","first-page":"e70849","DOI":"10.1371\/journal.pone.0070849","article-title":"Cannabinoid receptor CB2 modulates axon guidance","volume":"8","author":"Duff","year":"2013","journal-title":"PLoS ONE"},{"key":"B23","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1002\/9781444341256.ch10","article-title":"Neuropathology of Alzheimer's disease and its variants","volume-title":"in Neurodegeneration: The Molecular Pathology of Dementia and Movement Disorders, 2nd Edn.","author":"Duyckaerts","year":"2011"},{"key":"B24","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/1742-2094-2-29","article-title":"Stimulation of cannabinoid receptor 2 (CB2) suppresses microglial activation","volume":"2","author":"Ehrhart","year":"2005","journal-title":"J. Neuroinflammation"},{"key":"B25","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1016\/j.neulet.2006.06.012","article-title":"CB1 receptor selective activation inhibits beta-amyloid-induced iNOS protein expression in C6 cells and subsequently blunts tau protein hyperphosphorylation in co-cultured neurons","volume":"404","author":"Esposito","year":"2006","journal-title":"Neurosci. Lett."},{"key":"B26","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1124\/jpet.107.121566","article-title":"Opposing control of cannabinoid receptor stimulation on amyloid-beta-induced reactive gliosis: in vitro and in vivo evidence","volume":"322","author":"Esposito","year":"2007","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"B27","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1021\/mp060066m","article-title":"A molecular link between the active component of marijuana and Alzheimer's disease pathology","volume":"3","author":"Eubanks","year":"2006","journal-title":"Mol. Pharm."},{"key":"B28","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1111\/bph.12492","article-title":"The influence of cannabinoids on generic traits of neurodegeneration","volume":"171","author":"Fagan","year":"2014","journal-title":"Br. J. Pharmacol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1016\/j.neuropharm.2012.05.013","article-title":"WIN55212-2 attenuates amyloid-beta-induced neuroinflammation in rats through activation of cannabinoid receptors and PPAR-\u03b3 pathway","volume":"63","author":"Fakhfouri","year":"2012","journal-title":"Neuropharmacology"},{"key":"B30","doi-asserted-by":"publisher","first-page":"S91","DOI":"10.1016\/j.mce.2008.01.001","article-title":"Role of CB2 receptors in neuroprotective effects of cannabinoids","volume":"286","author":"Fern\u00e1ndez-Ruiz","year":"2008","journal-title":"Mol. Cell. Endocrinol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1007\/978-3-319-20825-1_8","article-title":"Endocannabinoids and neurodegenerative disorders: Parkinson's disease, Huntington's chorea, Alzheimer's disease, and others","volume":"231","author":"Fern\u00e1ndez-Ruiz","year":"2015","journal-title":"Handb. Exp. Pharmacol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1007\/s10863-009-9243-5","article-title":"Altered mitochondria, energy metabolism, voltage-dependent anion channel, and lipid rafts converge to exhaust neurons in Alzheimer's disease","volume":"41","author":"Ferrer","year":"2009","journal-title":"J. Bioenerg. Biomembr."},{"key":"B33","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.pneurobio.2012.03.005","article-title":"Defining Alzheimer as a common age-related neurodegenerative process not inevitably leading to dementia","volume":"397","author":"Ferrer","year":"2012","journal-title":"Prog. Neurobiol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"1895","DOI":"10.1111\/febs.12212","article-title":"Transport of endocannabinoids across the plasma membrane and within the cell","volume":"280","author":"Fowler","year":"2013","journal-title":"FEBS. J."},{"key":"B35","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1007\/s12035-010-8137-1","article-title":"Why pleiotropic interventions are needed for Alzheimer's disease","volume":"41","author":"Frautschy","year":"2010","journal-title":"Mol. Neurobiol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"1778","DOI":"10.1212\/WNL.0b013e31828726f5","article-title":"Alzheimer disease in the United States (2010-2050) estimated using the 2010 census","volume":"80","author":"Hebert","year":"2013","journal-title":"Neurology"},{"key":"B37","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1016\/S1474-4422(15)70016-5","article-title":"Neuroinflammation in Alzheimer's disease","volume":"14","author":"Heneka","year":"2015","journal-title":"Lancet Neurol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1038\/nature11729","article-title":"NLRP3 is activated in Alzheimer's disease and contributes to pathology in APP\/PS1 mice","volume":"493","author":"Heneka","year":"2013","journal-title":"Nature"},{"key":"B39","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1038\/nri3705","article-title":"Innate immune activation in neurodegenerative disease","volume":"14","author":"Heneka","year":"2014","journal-title":"Nat. Rev. Immunol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1007\/3-540-26573-2_2","article-title":"Cannabinoid receptor signaling","volume":"168","author":"Howlett","year":"2005","journal-title":"Handb. Exp. Pharmacol."},{"key":"B41","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1007\/978-3-319-20825-1_3","article-title":"Distribution of the endocannabinoid system in the central nervous system","volume":"231","author":"Hu","year":"2015","journal-title":"Handb. Exp. Pharmacol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.plipres.2016.02.002","article-title":"Endocannabinoids and endocannabinoid-related mediators: targets, metabolism and role in neurological disorders","volume":"62","author":"Iannotti","year":"2016","journal-title":"Prog. Lipid Res"},{"key":"B43","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/s10571-013-9984-x","article-title":"Cannabinoid effects on \u03b2 amyloid fibril and aggregate formation, neuronal and microglial-activated neurotoxicity","volume":"34","author":"Janefjord","year":"2014","journal-title":"in vitro. Cell. Mol. Neurobiol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1007\/s12035-007-8007-7","article-title":"Cannabinoid CB2 receptor-mediated anti-nociception in models of acute and chronic pain","volume":"36","author":"Jhaveri","year":"2007","journal-title":"Mol. Neurobiol."},{"key":"B45","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/nature12481","article-title":"Self-propagation of pathogenic protein aggregates in neurodegenerative diseases","volume":"501","author":"Jucker","year":"2013","journal-title":"Nature"},{"key":"B46","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1046\/j.1471-4159.2000.0750436.x","article-title":"Impaired proteasome function in Alzheimer's disease","volume":"75","author":"Keller","year":"2000","journal-title":"J. Neurochem."},{"key":"B47","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1113\/jphysiol.2014.286633","article-title":"Chronic activation of CB2 cannabinoid receptors in the hippocampus increases excitatory synaptic transmission","volume":"593","author":"Kim","year":"2015","journal-title":"J. Physiol."},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2016.03.015","article-title":"Stimulation of brain glucose uptake by cannabinoid CB(2) receptors and its therapeutic potential in Alzheimer's disease","author":"K\u00f6falvi","year":"2016","journal-title":"Neuropharmacology."},{"key":"B49","doi-asserted-by":"publisher","first-page":"29","DOI":"10.2119\/molmed.2013.00140","article-title":"CB2 receptor deficiency increases amyloid pathology and alters tau processing in a transgenic mouse model of Alzheimer's disease. Mol","volume":"20","author":"Koppel","year":"2014","journal-title":"Med."},{"key":"B50","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1002\/hipo.22558","article-title":"Deletion of CB2 cannabinoid receptors reduces synaptic transmission and long-term potentiation in the mouse hippocampus","volume":"26","author":"Li","year":"2016","journal-title":"Hippocampus"},{"key":"B51","doi-asserted-by":"publisher","first-page":"615","DOI":"10.2174\/156800705774933104","article-title":"Endocannabinoid metabolic pathways and enzymes","volume":"4","author":"Ligresti","year":"2005","journal-title":"Curr. Drug Targets CNS Neurol. Disord."},{"key":"B52","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1016\/j.micinf.2015.04.004","article-title":"Infection, systemic inflammation, and Alzheimer's disease","volume":"17","author":"Lim","year":"2015","journal-title":"Microbes Infect."},{"key":"B53","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1097\/NEN.0000000000000176","article-title":"Neuroinflammatory signals in Alzheimer disease and APP\/PS1 transgenic mice: correlations with plaques, tangles, and oligomeric species","volume":"74","author":"L\u00f3pez-Gonz\u00e1lez","year":"2015","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"B54","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.neuroscience.2011.02.035","article-title":"Neurochemical basis of cannabis addiction","volume":"181","author":"Maldonado","year":"2011","journal-title":"Neuroscience"},{"key":"B55","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/1742-2094-9-8","article-title":"Prolonged oral cannabinoid administration prevents neuroinflammation, lowers \u03b2-amyloid levels and improves cognitive performance in Tg APP 2576 mice","volume":"9","author":"Mart\u00edn-Moreno","year":"2012","journal-title":"J. Neuroinflammation"},{"key":"B56","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1124\/mol.111.071290","article-title":"Cannabidiol and other cannabinoids reduce microglial activation in vitro and in vivo: relevance to Alzheimer's disease","volume":"79","author":"Mart\u00edn-Moreno","year":"2011","journal-title":"Mol. Pharmacol."},{"key":"B57","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1517\/14728222.2014.988707","article-title":"Targeting microglia for the treatment of Alzheimer's disease","volume":"19","author":"McGeer","year":"2015","journal-title":"Expert Opin. Ther. Targets"},{"key":"B58","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/j.bbi.2015.06.002","article-title":"Endocannabinoids drive the acquisition of an alternative phenotype in microglia","volume":"49","author":"Mecha","year":"2015","journal-title":"Brain Behav. Immun."},{"key":"B59","doi-asserted-by":"publisher","first-page":"1781","DOI":"10.1126\/science.1131864","article-title":"Exogenous induction of cerebral beta-amyloidogenesis is governed by agent and host","volume":"313","author":"Meyer-Luehmann","year":"2006","journal-title":"Science"},{"key":"B60","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1196\/annals.1427.007","article-title":"Brain glucose hypometabolism and oxidative stress in preclinical Alzheimer's disease","volume":"1147","author":"Mosconi","year":"2008","journal-title":"Ann. N.Y. Acad. Sci."},{"key":"B61","doi-asserted-by":"publisher","first-page":"201","DOI":"10.14336\/AD.2015.1007","article-title":"Mitochondrial dysfunction in Alzheimer's disease and the rationale for bioenergetics based therapies","volume":"7","author":"Onyango","year":"2016","journal-title":"Aging Dis."},{"key":"B62","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1074\/jbc.M111.291294","article-title":"CB2 cannabinoid receptors promote neural progenitor cell proliferation via mTORC1 signaling","volume":"287","author":"Palazuelos","year":"2012","journal-title":"J. Biol. Chem."},{"key":"B63","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1124\/pr.110.003004","article-title":"International union of basic and clinical pharmacology. LXXIX. Cannabinoid receptors and their ligands: beyond CB1 and CB2","volume":"62","author":"Pertwee","year":"2010","journal-title":"Pharmacol. Rev."},{"key":"B64","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/978-3-319-20825-1_1","article-title":"Endocannabinoids and their pharmacological actions","volume":"231","author":"Pertwee","year":"2015","journal-title":"Handb. Exp. Pharmacol."},{"key":"B65","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/b137831","article-title":"Pharmacological actions of cannabinoids","volume":"168","author":"Pertwee","year":"2005","journal-title":"Handb. Exp. Pharmacol."},{"key":"B66","doi-asserted-by":"publisher","first-page":"1904","DOI":"10.1523\/JNEUROSCI.4540-04.2005","article-title":"Prevention of Alzheimer's disease pathology by cannabinoids: neuroprotection mediated by blockade of microglial activation","volume":"25","author":"Ram\u00edrez","year":"2005","journal-title":"J. Neurosci."},{"key":"B67","doi-asserted-by":"publisher","first-page":"e0129618","DOI":"10.1371\/journal.pone.0129618","article-title":"Cannabinoid CB2 receptors in a mouse model of A\u03b2 amyloidosis: immunohistochemical analysis and suitability as a PET biomarker of neuroinflammation","volume":"10","author":"Savonenko","year":"2015","journal-title":"PLoS ONE"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(15)01124-1","article-title":"Alzheimer's disease","author":"Scheltens","year":"2016","journal-title":"Lancet"},{"key":"B69","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1016\/j.neurobiolaging.2014.09.019","article-title":"Cannabinoid receptor 2 deficiency results in reduced neuroinflammation in an Alzheimer's disease mouse model","volume":"36","author":"Schm\u00f6le","year":"2015","journal-title":"Neurobiol. Aging"},{"key":"B70","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1016\/j.neurobiolaging.2012.06.005","article-title":"CB2 receptor and amyloid pathology in frontal cortex of Alzheimer's disease patients","volume":"34","author":"Solas","year":"2013","journal-title":"Neurobiol. Aging"},{"key":"B71","doi-asserted-by":"publisher","first-page":"11025","DOI":"10.1073\/pnas.1206555109","article-title":"Purified and synthetic Alzheimer's amyloid beta (A\u03b2) prions","volume":"109","author":"St\u00f6hr","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B72","doi-asserted-by":"publisher","first-page":"341","DOI":"10.3233\/JAD-2010-1222","article-title":"Role of oxidative stress in the progression of Alzheimer's disease. J","volume":"19","author":"Sultana","year":"2010","journal-title":"Alzheimers Dis."},{"key":"B73","doi-asserted-by":"publisher","first-page":"1791","DOI":"10.1212\/WNL.58.12.1791","article-title":"Phases of A beta-deposition in the human brain and its relevance for the development of AD","volume":"58","author":"Thal","year":"2002","journal-title":"Neurology"},{"key":"B74","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.brainres.2009.05.098","article-title":"The activation of cannabinoid CB2 receptors stimulates in situ and in vitro beta-amyloid removal by human macrophages","volume":"1283","author":"Tol\u00f3n","year":"2009","journal-title":"Brain Res."},{"key":"B75","doi-asserted-by":"publisher","first-page":"2756068","DOI":"10.1155\/2016\/2756068","article-title":"It is all about (U)biquitin: role of altered ubiquitin-proteasome system and UCHL1 in Alzheimer Disease","volume":"2016","author":"Tramutola","year":"2016","journal-title":"Oxid. Med. Cell. Longev."},{"key":"B76","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1523\/JNEUROSCI.23-04-01398.2003","article-title":"Nonpsychotropic cannabinoid receptors regulate microglial cell migration. J","volume":"23","author":"Walter","year":"2003","journal-title":"Neurosci."},{"key":"B77","doi-asserted-by":"publisher","first-page":"917","DOI":"10.2174\/092986707780363023","article-title":"The role of the cannabinoid CB2 receptor in pain transmission and therapeutic potential of small molecule CB2 receptor agonists","volume":"14","author":"Whiteside","year":"2007","journal-title":"Curr. Med. Chem."},{"key":"B78","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1126\/science.1063545","article-title":"Endocannabinoid signaling in the brain","volume":"296","author":"Wilson","year":"2002","journal-title":"Science"},{"key":"B79","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1038\/sj.bjp.0707486","article-title":"Cannabinoid CB2 receptors in the gastrointestinal tract: a regulatory system in states of inflammation","volume":"153","author":"Wright","year":"2008","journal-title":"Br. J. Pharmacol."},{"key":"B80","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1016\/j.neurobiolaging.2012.06.011","article-title":"Activation of the CB2 receptor system reverses amyloid-induced memory deficiency","volume":"34","author":"Wu","year":"2013","journal-title":"Neurobiol. Aging"}],"container-title":["Frontiers in Neuroscience"],"original-title":[],"deposited":{"date-parts":[[2019,9,8]],"date-time":"2019-09-08T21:58:27Z","timestamp":1567979907000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/Article\/10.3389\/fnins.2016.00243\/abstract"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5,31]]},"references-count":80,"URL":"https:\/\/doi.org\/10.3389\/fnins.2016.00243","relation":{},"ISSN":["1662-453X"],"issn-type":[{"value":"1662-453X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,5,31]]}}}